Zhang and Zhu further support the oncogenic role of miR-103a-3p in CRC by demonstrating its regulation of GREM2, a modulator of the TGF-β pathway, which also intersects with metabolic and oxidative stress responses [107]. This evidence concerns the gene TGFB1 and colorectal carcinoma.